Phthalazines with angiogenesis inhibiting activity
    1.
    发明授权
    Phthalazines with angiogenesis inhibiting activity 失效
    具有血管生成抑制活性的酞嗪类

    公开(公告)号:US06710047B2

    公开(公告)日:2004-03-23

    申请号:US10338062

    申请日:2003-01-07

    IPC分类号: A61K31495

    摘要: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* or (iii) together form a bridge in subformula I** wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; R is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etheritied or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, phenyl-lower alkylthio, alkylphenylthio, phenylsulfinyl, phenyl-lower alkylsulfinyl, alkylphenylsulfinyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, or alkylphenylsulfony; and wherein the bonds characterized by a wavy line are either single or double bonds; or an N-oxide of said compound with the stipulation that, if Y is pyridyl or unsubstituted cycloalkyl, X is imino, and the remaining radicals are as defined, then G is selected from the group comprising lower alkylene, —CH2—O—, —CH2—S—, oxa and thia; or a salt thereof. The compounds inhibit angiogenesis.

    摘要翻译: 本发明涉及式I化合物,其中r为0至2,n为0至2; m为0〜4; R1和R2(i)在每种情况下都是低级烷基,或(ii)一起在子式I *中形成桥,或(iii)一起形成子式I **中的桥,其中一个或两个环成员T1,T2 ,T3和T4是氮,余数分别为CH; A,B,D和E是N或CH,其中不多于2个这些基团是N; G是低级亚烷基,酰氧基或羟基 - 低级亚烷基,-CH 2 -O-,-CH 2 -S-,-CH 2 -NH-,氧杂,硫杂或亚氨基; Q是甲基; R是H或低级烷基; X是亚氨基,氧杂或硫杂; Y是芳基,吡啶基或(未)取代的环烷基; 羟基,醚基或酯化的羟基,硝基,氰基,羧基,酯化的羧基,烷酰基,氨基甲酰基,N-单或N,N-二取代的氨基甲酰基,脒基, 胍基,巯基,磺基,苯硫基,苯基 - 低级烷硫基,烷基苯硫基,苯基亚磺酰基,苯基 - 低级烷基亚磺酰基,烷基苯基亚磺酰基,苯基磺酰基,苯基 - 低级烷基磺酰基或烷基苯基磺酰基。 并且其中以波浪线表征的键是单键或双键; 或所述化合物的N-氧化物,其规定如果Y是吡啶基或未取代的环烷基,则X是亚氨基,剩余的基团如所定义,则G选自低级亚烷基,-CH 2 -O-, -CH 2 -S-,氧杂和硫杂; 或其盐。 该化合物抑制血管发生。

    Phthalazines with angiogenesis inhibiting activity
    2.
    发明授权
    Phthalazines with angiogenesis inhibiting activity 有权
    具有血管生成抑制活性的酞嗪类

    公开(公告)号:US06258812B1

    公开(公告)日:2001-07-10

    申请号:US09367273

    申请日:1999-10-20

    IPC分类号: A61K31498

    摘要: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* (I*) or (iii) together form a bridge in subformula I** (I**), wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; c is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etherified or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, phenyl-lower alkylthio, alkylphenylthio, phenylsulfinyl, phenyl-lower alkylsulfinyl, alkylphenylsulfinyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, or alkylphenylsulfony; and wherein the bonds characterized by a wavy line are either single or double bonds; or an N-oxide of said compound with the stipulation that, if Y is pyridyl or unsubstituted cycloalkyl, X is imino, and the remaining radicals are a s defined, then G is selected from the group comprising lower alkylene, —CH2—O—, CH2—S—, oxa and thia; or a salt thereof. The compounds inhibit angiogenesis.

    摘要翻译: 本发明涉及式I化合物,其中r为0至2,n为0至2; m为0〜4; R1和R2(i)在每种情况下都是低级烷基,或(ii)一起在子式I *(I *)中形成桥,或(iii)一起形成子式I **(I **)中的桥,其中 环成员T1,T2,T3和T4中的一个或两个是氮,余下的都是CH; A,B,D和E是N或CH,其中不多于2个这些基团是N; G是低级亚烷基,酰氧基或羟基 - 低级亚烷基,-CH 2 -O-,-CH 2 -S-,-CH 2 -NH-,氧杂,硫杂或亚氨基; Q是甲基; c是H或低级烷基; X是亚氨基,氧杂或硫杂; Y是芳基,吡啶基或(未)取代的环烷基; 羟基,醚化或酯化的羟基,硝基,氰基,羧基,酯化的羧基,烷酰基,氨基甲酰基,N-单或N,N-二取代的氨基甲酰基,脒基, 胍基,巯基,磺基,苯硫基,苯基 - 低级烷硫基,烷基苯硫基,苯基亚磺酰基,苯基 - 低级烷基亚磺酰基,烷基苯基亚磺酰基,苯基磺酰基,苯基 - 低级烷基磺酰基或烷基苯基磺酰基。 并且其中以波浪线表征的键是单键或双键; 或所述化合物的N-氧化物,其规定如果Y是吡啶基或未取代的环烷基,则X是亚氨基,剩余的基团如所定义,则G选自低级亚烷基,-CH 2 -O-, CH2-S-,氧杂和硫杂; 或其盐。 该化合物抑制血管发生。

    Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity
    3.
    发明授权
    Pyrido-, pyrimido-, pyridazo- and pyrazo- pyridazines having angiogenesis inhibiting activity 失效
    具有血管生成抑制活性的吡啶 - ,嘧啶并 - 哒嗪 - 和吡唑并 - 哒嗪

    公开(公告)号:US06514974B2

    公开(公告)日:2003-02-04

    申请号:US09859858

    申请日:2001-05-17

    IPC分类号: A61K3150

    摘要: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* or (iii) together form a bridge in subformula I** wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; R is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etherified or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, phenyl-lower alkylthio, alkylphenylthio, phenylsulfinyl, phenyl-lower alkylsulfinyl, alkylphenylsulfinyl, phenylsulfonyl, phenyl-lower alkylsulfonyl, or alkylphenylsulfony; and wherein the bonds characterized by a wavy line are either single or double bonds; or an N-oxide of said compound with the stipulation that, if Y is pyridyl or unsubstituted cycloalkyl, X is imino, and the remaining radicals are as defined, then G is selected from the group comprising lower alkylene, —CH2—O—, —CH2—S—, oxa and thia; or a salt thereof. The compounds inhibit angiogenesis.

    摘要翻译: 本发明涉及式I化合物,其中r为0至2,n为0至2; m为0〜4; R1和R2(i)在每种情况下都是低级烷基,或(ii)一起在子式I *中形成桥,或(iii)一起形成子式I **中的桥,其中一个或两个环成员T1,T2 ,T3和T4是氮,余数分别为CH; A,B,D和E是N或CH,其中不多于2个这些基团是N; G是低级亚烷基,酰氧基或羟基 - 低级亚烷基,-CH 2 -O-,-CH 2 -S-,-CH 2 -NH-,氧杂,硫杂或亚氨基; Q是甲基; R为H或低级烷基; X是亚氨基,氧杂或硫杂; Y是芳基,吡啶基或(未)取代的环烷基; 羟基,醚化或酯化的羟基,硝基,氰基,羧基,酯化的羧基,烷酰基,氨基甲酰基,N-单或N,N-二取代的氨基甲酰基,脒基, 胍基,巯基,磺基,苯硫基,苯基 - 低级烷硫基,烷基苯硫基,苯基亚磺酰基,苯基 - 低级烷基亚磺酰基,烷基苯基亚磺酰基,苯基磺酰基,苯基 - 低级烷基磺酰基或烷基苯基磺酰基。 并且其中以波浪线表征的键是单键或双键; 或所述化合物的N-氧化物,其规定如果Y是吡啶基或未取代的环烷基,则X是亚氨基,剩余的基团如所定义,则G选自低级亚烷基,-CH 2 -O-, -CH 2 -S-,氧杂和硫杂; 或其盐。 该化合物抑制血管发生。

    Antitumor antisense oligonucleotides
    4.
    发明授权
    Antitumor antisense oligonucleotides 失效
    抗肿瘤反义寡核苷酸

    公开(公告)号:US6018042A

    公开(公告)日:2000-01-25

    申请号:US914961

    申请日:1997-08-20

    摘要: The invention relates to deoxyribo- and ribo-oligonucleotides and derivatives thereof, as well as pharmaceutical preparations, therapies, diagnostics and commercial research reagents in relation to disease states which respond to modulation of the synthesis of the enzyme S-adenosylmethionine decarboxylase (SAMDC). In particular, the invention relates to antisense oligonucleotides and oligonucleotide derivatives specifically hybridizable with nucleic acids relating to (preferably human) SAMDC. These oligonucleotides and their derivatives have been found to modulate the synthesis of SAMDC in cells.

    摘要翻译: 本发明涉及脱氧核糖核苷酸和核糖寡核苷酸及其衍生物,以及与对S-腺苷甲硫氨酸脱羧酶(SAMDC)的合成的调节有关的疾病状态的药物制剂,疗法,诊断和商业研究试剂。 具体地,本发明涉及与与(优选人类)SAMDC相关的核酸特异性杂交的反义寡核苷酸和寡核苷酸衍生物。 已经发现这些寡核苷酸及其衍生物调节细胞中SAMDC的合成。